Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Alexandru Stieber Explores VEXAS Syndrome
Alexandru Stieber/LinkedIn
Dec 18, 2025, 13:34

Alexandru Stieber Explores VEXAS Syndrome

Alexandru Stieber, Internal Medicine Resident at SUUMC Bucharest, shared on LinkedIn:

”Second set of scientific updates from the SNFMI Congress that took place last week in Tours, France.

The theme of today’s post revolves around VEXAS syndrome, new implications for patients with a VEXAS-like phenotype and the evolving concept of “clonal hematopoiesis of immunological significance” (CHIS).

  • proven efficacy of azacitidine treatment in VEXAS patients, even in the absence of myelodysplastic syndrome
  • proven pathophysiology of UBA1 mutated myeloid cells that drive an inflammatory millieu which alters normal hematopoiesis
  • new links found between clonalhematopoiesis with IDH mutations and inflammatory manifestations (polymyalgia rheumatica and large-vessel vasculitis), with resolution under targeted inhibitors”

Alexandru Stieber Explores VEXAS Syndrome

Stay updated with Hemostasis Today.

Alexandru Stieber CHIS Health Hematology Hemostasis Hemostasis Today IDH Medicine olymyalgia rheumatica SNFMI UBA1 Vasculitis Vexas
NewsFeed